![](/img/cover-not-exists.png)
97 Treatment of chronic myelogenous leukemia (CML) relapsing after myeloablative stem cell transplantation with STI-571 (imatinib mesylate) with or without donor lymphocyte infusion (DLI)
J.A. Barrett, M. Battiwala, S. Solomon, R. Childs, N. Hensel, L. Wehrlen, R. KurlanderVolume:
9
Year:
2003
Language:
english
DOI:
10.1016/s1083-8791(03)80098-8
File:
PDF, 147 KB
english, 2003